Latest News of PHR
The No. 1 phrase people who are good at small talk always use, says Stanford public speaking expert
By CNBC |
5 days ago
"Tell me more" is a supportive response that encourages the other person to share more. A "shift" response shifts the conversation back to you. Using more support responses in small talk can make conv...
Humphrey runs for 159 yards, 3 TDs to lead Montana State to 37-17 win over Idaho State
By AP NEWS |
1 week ago
Montana State defeated Idaho State 37-17 in a Big Sky Conference game. Scottre Humprey led with 159 rushing yards and 3 touchdowns. The Bobcats struggled until Tommy Mellott's 70-yard touchdown pass t...
Ontario man was suffering schizophrenia years before he killed his parents: defence - Toronto | Globalnews.ca
By Global News |
1 week ago
Kyle Sequeira, who was found not criminally responsible for killing his parents due to mental illness, admitted to an aggravated assault two years prior. Sequeira was intoxicated and suffered from sub...
-
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
By Fox News | 1 week agoThe FDA approved a new drug called COBENFY for schizophrenia treatment in adults, offering a novel approach to managing the disorder. This marks a significant advancement in the field after several de...
-
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
By Yahoo! Finance | 1 week agoFDA approved Bristol Myers Squibb's Cobenfy for schizophrenia in adults, without a boxed warning, signaling a positive outlook. Analysts project high sales for Cobenfy in treating Alzheimer's psychosi...
-
BMS wins approval for schizophrenia drug acquired from Karuna
By Yahoo! Finance | 1 week agoThe FDA has approved Bristol Myers Squibb's novel schizophrenia drug Cobenfy, offering a new treatment option by targeting cholinergic receptors instead of dopamine receptors. Clinical trials show eff...
-
FDA approves new type of schizophrenia drug
By The Hill | 1 week agoThe FDA approved a new schizophrenia drug, Cobenfy, offering a unique treatment approach. This drug targets a different receptor than traditional antipsychotics. Schizophrenia is a severe mental illne...
-
FDA approves new schizophrenia drug in 70-year first
By Newsweek | 1 week agoThe FDA has approved a new schizophrenia drug, Cobenfy, offering hope to patients with treatment-resistant symptoms. Targeting muscarinic receptors, it promises a new approach to managing the conditio...
-
This FDA-approved drug promises a new way to treat schizophrenia
By USA Today | 1 week agoThe FDA approved Bristol Myers Squibb's new drug, KarXT, for schizophrenia. It combines Xanomeline and trospium to improve symptoms with fewer side effects. The medication, now named Cobenfy, offers h...
-
BMY Stock Signals Breakout As FDA OKs Schizophrenia Drug
By Investor's Business Daily | 1 week agoBristol-Myers Squibb received FDA approval for Cobenfy, a groundbreaking schizophrenia drug that doesn't block dopamine directly. The stock surged as a result....
-
F.D.A. Approves the First New Schizophrenia Drug in Decades
By The New York Times | 1 week agoThe FDA approved a new antipsychotic drug, Cobenfy, designed to treat schizophrenia without the common side effects of weight gain. It works by indirectly influencing dopamine levels through acetylcho...
-
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
By CNBC | 1 week agoA new pill called Cobenfy by Bristol Myers Squibb aims to help the 3 million adults in the U.S. living with schizophrenia. The drug offers hope for patients struggling with existing treatments and pro...
-
5 Worst Cars To Buy That Will Kill Your Wealth, According to Humphrey Yang
By Yahoo! Finance | 1 week agoFinancial expert Humphrey Yang shares insights on the worst cars to buy that will deplete your wealth, including the Cadillac Escalade ESV, BMW 5 Series Hybrid, Maserati Ghibli, BMW 7 Series, and Mase...
-
Stocks Showing Improving Market Leadership: Phreesia Earns 89 RS Rating
By Investor's Business Daily | 1 month agoLearn how to buy stocks by understanding a stock's personality type. Top-performing stocks typically have an RS Rating of 80 or more. Look for stocks breaking out with strong earnings and sales growth...
-
Sphere Entertainment Co. (SPHR): Among Jim Cramer's Stock Picks You Need to Know
By Yahoo! Finance | 1 month agoJim Cramer discusses the market's unpredictability and sector performances, emphasizing the impact of irrational fears on stock sell-offs. He analyzes Sphere Entertainment Co.'s growth potential and f...